Warning: Undefined variable $zfal in C:\Inetpub\vhosts\kidney.de\httpdocs\mlpefetch.php on line 525
Deprecated: str_replace(): Passing null to parameter #3 ($subject) of type array|string is deprecated in C:\Inetpub\vhosts\kidney.de\httpdocs\mlpefetch.php on line 525
Warning: Undefined variable $sterm in C:\Inetpub\vhosts\kidney.de\httpdocs\mlpefetch.php on line 530
free
Warning: Undefined variable $sterm in C:\Inetpub\vhosts\kidney.de\httpdocs\mlpefetch.php on line 531
free free
English Wikipedia
Nephropedia Template TP (
Twit Text
DeepDyve Pubget Overpricing |
lüll Potassium channels--multiplicity and challenges Jenkinson DHBr J Pharmacol 2006[Jan]; 147 Suppl 1 (Suppl 1): S63-71The development of our knowledge of the function, structure and pharmacology of K(+) channels is briefly outlined. This is the most diverse of all the ion channel families with at least 75 coding genes in mammals. Alternative splicing as well as variations in the channel subunits and accessory proteins that co-assemble to form the functional channel add to the multiplicity. Whereas diversity of this order suggests that it may be possible to develop new classes of drug, for example, for immunomodulation and some diseases of the central nervous system, the ubiquity of K(+) channels imposes stringent requirements for selectivity. Animal toxins from the snake, bee and scorpion provide useful leads, though only in a few instances (e.g. with apamin) it has been possible to produce non-peptidic analogues of high potency. The scale of the resources needed to identify, and characterize fully, specific K(+) channel as targets and then develop modulators with the required selectivity presents a challenge to both academic and applied pharmacologists.|*Potassium Channels/drug effects/genetics/physiology[MESH]|Animals[MESH]|Anticonvulsants/therapeutic use[MESH]|Cardiovascular Diseases/drug therapy[MESH]|History, 20th Century[MESH]|History, 21st Century[MESH]|Humans[MESH]|Immunosuppressive Agents/therapeutic use[MESH]|Ion Channel Gating[MESH]|Potassium Channel Blockers/chemistry/pharmacology/therapeutic use[MESH]|Protein Conformation[MESH] |